It's a natural part of aging, but at some point, it can lead to a condition called benign prostatic hyperplasia (BPH). Benign prostatic hyperplasia is a condition that causes your prostate to grow ...

MarinHealth Medical Center Surgeons Perform New AI-Powered Aquablation Procedure for the Treatment of Benign Prostatic ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

A full market release of the HYDROS System is expected within the current quarter.

The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with ...

Objective: To determine the efficacy and tolerability of low-dose tamsulosin 0.2 mg/day in Chinese patients with symptomatic benign prostatic hyperplasia (BPH). Conclusions: Low-dose tamsulosin 0. ...

--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH). MarinHealth is ...

You have full access to this article via your institution. The authors highlight that individualization of therapy on the basis of patients' genetic features could revolutionize medicine, and ...

Introduction Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate commonly encountered in older men. BPH has been treated with acupuncture inside and outside China, but ...

Anticipated growth for ‘Saudi Arabia Benign Prostatic Hyperplasia Treatment Market’ is significant from 2024 to 2032. The market showed steady growth in 2024 and is expected to continue rising due to ...

Prostate removal surgery, whether due to benign prostatic hyperplasia (BPH) or other reasons is a common medical procedure.